Iteos Therapeutics Price Prediction

Intrinsic Valuation Low Real High 8.15 8.63 11.17 Details

Naive Forecast Low Next High 9.65 10.13 10.61 Details

Bollinger Band Projection (param) Lower Middle Band Upper 10.13 10.15 10.17 Details

Iteos Therapeutics After-Hype Price Prediction Density Analysis

Iteos Therapeutics Estimiated After-Hype Price Volatility

Iteos Therapeutics Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.03	0.48	0.00	0.00	7 Events / Month	7 Events / Month	In about 7 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
10.15	10.15	0.00	1,200   Notes

Iteos Therapeutics Hype Timeline

Iteos Therapeutics is currently traded for 10.15. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Iteos is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.03%. %. The volatility of related hype on Iteos Therapeutics is about 332.31%, with the expected price after the next announcement by competition of 10.15. About 90.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Iteos Therapeutics recorded a loss per share of 4.73. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Iteos Therapeutics Related Hype Analysis

Iteos Therapeutics Additional Predictive Modules

Most predictive techniques to examine Iteos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Iteos using various technical indicators. When you analyze Iteos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Iteos Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Iteos Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Iteos Therapeutics based on analysis of Iteos Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Iteos Therapeutics depends on current market conditions and Iteos Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Iteos Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Iteos Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Iteos Therapeutics' future price predictability will typically decrease when Iteos Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Iteos Therapeutics often depends not only on the future outlook of the potential Iteos Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Iteos Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

If you are still planning to invest in Iteos Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Iteos Therapeutics' history and understand the potential risks before investing.